参考文献/References:
[1] 方向华,王淳秀,梅利平,等.脑卒中流行病学研究进展[J].中华流行病学杂志,2011,32(9):847-853.
[2] Liu M,Wang H,Liu J,et al.Therapeutic effect of recombinant tissue plasminogen activator on acute cerebral infarction at different times[J].World J Emerg Med,2013,4(3):205.
[3] 党哲,张国鲁,张微微,等.rt-PA联合尿激酶静脉溶栓治疗急性脑梗死的疗效及安全性研究[J].脑与神经疾病杂志,2014,22(4):287-291.
[4] 陈翠荣,赵振国,周媛,等.轻中度急性脑梗死MRI指导下超时间窗静脉溶栓治疗的研究[J].卒中与神经疾病,2014,21(6):330-333.
[5] 田洪,郝磊,宋川,等.急性脑梗死动脉溶栓治疗的疗效相关因素探讨[J].介入放射学杂志,2014,23(10):839-842.
[6] 中华医学会神经病学分会,中华医学会神经病学分会脑血管病学组.中国急性缺血性脑卒中诊治指南2014[J].中华神经科杂志,2015,48(4):246-257.
[7] Miteff F,Levi CR,Bateman GA,et al.The Independent predictive utility of computed tomography angiographic collateral status in acute ischaemic stroke[J].Brain,2009,132(Pt 8):2231-2238.
[8] Liu J,Wang Y,Akamatsu Y,et al.Vascular remodeling after ischemic stroke:mechanisms and therapeutic potentials[J].Prog Neurobiol,2014,115(4):138-156.
[9] Harrison MJ.The hematocrit and cerebrovascular accidents[J].Presse Med,1983,12(48):3095-3097.
[10] Vaya A,Suescun M.Hemorheological parameters as Independent predictors of venous thromboembolism[J].Clin Hemorheol Microcirc,2013,53(1/2):131-141.
[11] Kwaan HC.Role of plasma proteins in whole blood viscosity:A brief clinical review[J].Clin Hemorheol Microcirc,2010,44(3):167-176.
[12] 肖文,李仓霞,薛海龙,等.急性脑梗死患者血清纤维蛋白原、D-二聚体与颈动脉粥样硬化斑块的相关性研究[J].中华神经医学杂志,2012,11(3):266-268.
[13] Kaptoge S,Di Angelantonio E,Pennells LA,et al.C-Reactive protein,fibrinogen,and cardiovascular disease prediction[J].N Engl J Med,2012,367(14):1310-1320.
[14] 王建民,柳兆荣,梁子钧.脑血流量与血液粘度的相关性研究[J].微循环学,1998,8(1):43-45.
[15] Grotta J,Ackerman R,Correia J,et al.WHOLE-BLOOD VISCOSITY PARAMETERS AND CEREBRAL BLOOD-FLOW[J].Stroke,1982,13(3):296-301.
[16] 李昌盛,闵喆,湛彦强,等.利用激光散斑成像技术观察尤瑞克林对脑梗死大鼠脑血流的影响[J].中华神经科杂志,2010,43(10):732-736.
[17] 盛灿,李瑜霞,谢云燕,等.人尿激肽原酶对急性脑梗死侧支循环与脑血流灌注影响的多模态MRI研究[J].中国临床医学影像杂志,2016,27(2):77-81.
[18] Brown M M,Marshall J.Regulation of cerebral blood flow in response to changes in blood viscosity[J].Lancet,1985,325(8429):604-609.
[19] Xia C F,Yin H,Yao Y Y,et al.Kallikrein protects against ischemic stroke by inhibiting apoptosis and inflammation and promoting angiogenesis and neurogenesis[J].Hum Gene Ther,2006,17(2):206-219.
[20] Xia C F,Yin H,Borlongan C V,et al.Kallikrein gene transfer protects against ischemic stroke by promoting glial cell migration and inhibiting apoptosis[J].Hypertension,2004,43(2):452-459.